Table 3 Treatments for patients with acute leukemia and myelodysplastic syndrome

From: Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome

Treatment for AL/MDS Percent of patients
  AL (n=38) MDS (n=57)
HMA (azacitadine or decitabine) 8 28
Cytarabine-based 79 19
Allo-HSCT 11 5
Hyper-CVAD 8 0
IMID 3 11
FTI/TKI 3 9
Other 3 7
None 3 18
  1. Abbreviations: AL, acute leukemia; FTI, farnesyl transferase inhibitor; HMA, hypomethylating agent; HSCT, hematopoietic stem cell transplant; hyper-CVAD, hyper-fractionated cyclophosphamide, adriamycin, vincristine, dexamethasone; IMID, immune-modulating agent (thalidomide or lenalidomide); MDS, myelodysplastic syndrome; n, number; TKI, tyrosine kinase inhibitor.